ADVERTISEMENT

Pharma Q1 Results Review - Strong Overall Show; U.S. Visibility Improves: Nirmal Bang

Revlimid and price stabilisation drive U.S. growth; India business affected by seasonality and NLEM.

<div class="paragraphs"><p>Colorful pills. (Source: freepik)</p></div>
Colorful pills. (Source: freepik)
BQ Prime’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BQ Prime’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
To continue reading this story
You must be an existing Premium User
OUR NEWSLETTERS
By signing up you agree to the Terms & Conditions of NDTV Profit